|
EE05516B1
(et)
|
2002-09-25 |
2012-02-15 |
Memory@Pharmaceuticals@Corporation |
Indasoolid bensotiasoolid ja bensoisotiasoolid nende valmistamine ning kasutamine
|
|
FR2845382A1
(fr)
|
2002-10-02 |
2004-04-09 |
Sanofi Synthelabo |
Derives d'indazolecarboxamides, leur preparation et leur utilisation en therapeutique
|
|
US20070043079A1
(en)
*
|
2003-04-18 |
2007-02-22 |
Hiromu Habashita |
Heterocyclic compound containing nitrogen atom and use thereof
|
|
BRPI0412259B1
(pt)
|
2003-07-22 |
2019-08-20 |
Astex Therapeutics Limited |
Compostos de 1H-pirazol 3,4-dissubstituídos como moduladores de quinases dependentes de ciclina (CDK), seus usos, processo para a preparação dos mesmos e composição farmacêutica
|
|
WO2005014554A1
(en)
*
|
2003-08-08 |
2005-02-17 |
Astex Therapeutics Limited |
1h-indazole-3-carboxamide compounds as mapkap kinase modulators
|
|
JP2007501804A
(ja)
*
|
2003-08-08 |
2007-02-01 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
電位開口型のナトリウムチャネルのインヒビターとして有用な組成物
|
|
SG149830A1
(en)
|
2003-12-22 |
2009-02-27 |
Memory Pharm Corp |
Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2- benzisothiazoles, and preparation and uses thereof
|
|
FR2867778B1
(fr)
*
|
2004-03-16 |
2006-06-09 |
Sanofi Synthelabo |
Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme
|
|
SG165199A1
(en)
|
2004-03-25 |
2010-10-28 |
Memory Pharm Corp |
Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof
|
|
ATE487716T1
(de)
|
2004-04-22 |
2010-11-15 |
Memory Pharm Corp |
Indole, 1h-indazole, 1,2-benzisoxazole, 1,2- benzoisothiazole, deren herstellung und verwendungen
|
|
RU2386633C2
(ru)
|
2004-05-07 |
2010-04-20 |
Мемори Фармасьютиклз Корпорейшн |
1h-индазолы, бензотиазолы, 1, 2-бензоизоксазолы, 1, 2-бензоизотиазолы и хромоны и их получение и применения
|
|
CA2583217C
(en)
|
2004-10-18 |
2011-05-31 |
Amgen Inc. |
1,3,4-thiadiazole compounds as protein kinase inhibitors
|
|
PL1828179T3
(pl)
|
2004-12-22 |
2010-08-31 |
Memory Pharm Corp |
Ligandy dla receptorów nikotynowych alfa-7 przeciwko chorobom związanym z OUN
|
|
AR054425A1
(es)
|
2005-01-21 |
2007-06-27 |
Astex Therapeutics Ltd |
Sales de adicion de piperidin 4-il- amida de acido 4-(2,6-dicloro-benzoilamino) 1h-pirazol-3-carboxilico.
|
|
AR053662A1
(es)
*
|
2005-01-21 |
2007-05-16 |
Astex Therapeutics Ltd |
Compuestos de pirazol inhibidores de la actividad quinasa cdk y gsk
|
|
US8404718B2
(en)
|
2005-01-21 |
2013-03-26 |
Astex Therapeutics Limited |
Combinations of pyrazole kinase inhibitors
|
|
JP2009507843A
(ja)
*
|
2005-09-09 |
2009-02-26 |
シェーリング コーポレイション |
アザ縮合サイクリン依存性キナーゼ阻害剤
|
|
MX2008012482A
(es)
*
|
2006-03-31 |
2008-10-10 |
Abbott Lab |
Compuestos de indazol.
|
|
WO2007129062A1
(en)
*
|
2006-05-08 |
2007-11-15 |
Astex Therapeutics Limited |
Pharmaceutical combinations of diazole derivatives for cancer treatment
|
|
CA2693473A1
(en)
|
2007-07-17 |
2009-01-22 |
Amgen Inc. |
Thiadiazole modulators of pkb
|
|
US7897619B2
(en)
|
2007-07-17 |
2011-03-01 |
Amgen Inc. |
Heterocyclic modulators of PKB
|
|
WO2009106980A2
(en)
*
|
2008-02-29 |
2009-09-03 |
Pfizer Inc. |
Indazole derivatives
|
|
EP2987487B1
(en)
|
2009-08-10 |
2020-10-07 |
Samumed, LLC |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
BR112012002942A2
(pt)
*
|
2009-08-10 |
2015-10-13 |
Epitherix Llc |
indazóis como inibidores da trilha de sinalização de wnt/b-catenina e empregos terapêuticos destes.
|
|
US20120172369A1
(en)
*
|
2009-09-14 |
2012-07-05 |
Ting Pauline C |
Inhibitors of diacylglycerol acyltransferase
|
|
PL3001903T3
(pl)
|
2009-12-21 |
2018-03-30 |
Samumed, Llc |
1H-pirazolo[3,4-b]pirydyny i ich zastosowania terapeutyczne
|
|
CA2799154A1
(en)
|
2010-05-12 |
2011-11-17 |
Abbvie Inc. |
Indazole inhibitors of kinase
|
|
WO2012118812A2
(en)
|
2011-02-28 |
2012-09-07 |
Epizyme, Inc. |
Substituted 6,5-fused bicyclic heteroaryl compounds
|
|
DK2755483T3
(en)
|
2011-09-14 |
2019-03-11 |
Samumed Llc |
INDAZOL-3-CARBOXAMIDES AND ITS USE AS WNT / B-CATENIN SIGNAL INHIBITORS
|
|
US9556131B2
(en)
*
|
2012-01-06 |
2017-01-31 |
University Of South Florida |
Compositions, methods of use, and methods of treatment
|
|
JP6141331B2
(ja)
*
|
2012-02-21 |
2017-06-07 |
アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニＡｚｉｅｎｄｅ Ｃｈｉｍｉｃｈｅ Ｒｉｕｎｉｔｅ Ａｎｇｅｌｉｎｉ Ｆｒａｎｃｅｓｃｏ Ａ．Ｃ．Ｒ．Ａ．Ｆ．Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ |
グリコーゲンシンターゼキナーゼ３ベータ阻害剤としての１ｈ−インダゾール−３−カルボキサミド化合物
|
|
EP2817301B1
(en)
|
2012-02-21 |
2015-12-23 |
AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO - A.C.R.A.F. - S.p.A. |
Use of 1h-indazole-3-carboxamide compounds as glycogen synthase kinase 3 beta inhibitors
|
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
|
CN104271133B
(zh)
|
2012-05-04 |
2017-10-13 |
萨穆梅德有限公司 |
1H‑吡唑并[3,4‑b]吡啶及其治疗应用
|
|
SG11201504754QA
(en)
*
|
2012-12-21 |
2015-07-30 |
Plexxikon Inc |
Compounds and methods for kinase modulation, and indications therefor
|
|
WO2014110086A2
(en)
*
|
2013-01-08 |
2014-07-17 |
Samumed, Llc |
3-(benzoimidazol-2-yl)-indazole inhibitors of the wnt signaling pathway and therapeutic uses thereof
|
|
SG10201914111XA
(en)
|
2014-03-20 |
2020-03-30 |
Samumed Llc |
5-substituted indazole-3-carboxamides and preparation and use thereof
|
|
WO2015200650A1
(en)
*
|
2014-06-25 |
2015-12-30 |
Epizyme, Inc. |
Substituted benzene and 6,5-fused bicyclic heteroaryl compounds
|
|
WO2016040182A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-1h-imidazo[4,5-c]pyridine and therapeutic uses thereof
|
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
|
WO2016040188A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
|
WO2017023972A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10206908B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
WO2017023987A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017024021A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
|
WO2017024026A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
WO2017023989A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
|
US10383861B2
(en)
|
2015-08-03 |
2019-08-20 |
Sammumed, LLC |
3-(1H-pyrrolo[2,3-C]pyridin-2-yl)-1H-pyrazolo[3,4-C]pyridines and therapeutic uses thereof
|
|
WO2017023996A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
|
WO2017023980A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
|
US10463651B2
(en)
|
2015-08-03 |
2019-11-05 |
Samumed, Llc |
3-(1H-pyrrolo[3,2-C]pyridin-2-YL)-1H-indazoles and therapeutic uses thereof
|
|
WO2017024003A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
|
KR20180080262A
(ko)
|
2015-11-06 |
2018-07-11 |
사뮤메드, 엘엘씨 |
골관절염의 치료
|
|
MX2018006250A
(es)
|
2015-11-18 |
2018-09-05 |
Genzyme Corp |
Biomarcador de enfermedad poliquistica renal y usos del mismo.
|
|
AR108325A1
(es)
|
2016-04-27 |
2018-08-08 |
Samumed Llc |
Isoquinolin-3-il carboxamidas y preparación y uso de las mismas
|
|
SMT202200486T1
(it)
|
2016-06-01 |
2023-01-13 |
Biosplice Therapeutics Inc |
Processo per la preparazione di n-(5-(3-(7-(3- fluorofen il)-3h-imidaz0[4,5-c]piridin-2-il)-1h-indazol-5- il)piridin-3-il)-3-metilbutanammide
|
|
KR102593742B1
(ko)
|
2016-10-21 |
2023-10-24 |
사뮤메드, 엘엘씨 |
인다졸-3-카복사마이드를 사용하는 방법 및 wnt/b-카테닌 신호전달 경로 억제제로서의 그들의 용도
|
|
MA46696A
(fr)
|
2016-11-07 |
2019-09-11 |
Samumed Llc |
Formulations injectables à dose unique prêtes à l'emploi
|
|
CA3082254A1
(en)
|
2016-11-21 |
2018-05-24 |
Translational Drug Development, Llc |
Heterocyclic compounds as kinase inhibitors
|
|
BR112019020277B1
(pt)
*
|
2017-03-28 |
2023-02-14 |
Basf Se |
Compostos, composição, método para combater ou controlar pragas de invertebrados, método para proteger plantas em crescimento, semente tratada, usos de um composto da fórmula i
|
|
MA51908A
(fr)
*
|
2018-02-23 |
2021-06-02 |
Samumed Llc |
Indazole-3-carboxamides substitués par hétéroaryle en position 5, préparation et utilisation associées
|
|
JP7411574B2
(ja)
|
2018-05-07 |
2024-01-11 |
アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニ |
グリコーゲンシンターゼキナーゼ３ベータ阻害剤としての１ｈ－インダゾール－３－カルボキサミド化合物
|
|
JP2023524465A
(ja)
|
2020-04-29 |
2023-06-12 |
プレキシコン インコーポレイティド |
複素環式化合物の合成
|
|
CN112778203B
(zh)
*
|
2021-01-29 |
2022-02-15 |
兰州交通大学 |
1h-吲唑-3-羧酸衍生物及格拉斯琼和氯尼达明的制备方法
|
|
CN114605329B
(zh)
*
|
2022-03-28 |
2024-01-26 |
河南中医药大学 |
取代的吲唑甲酰胺或取代的氮杂吲唑甲酰胺类flt3抑制剂及其用途
|
|
WO2024109642A1
(zh)
*
|
2023-07-28 |
2024-05-30 |
常州大学 |
一种苯并氮杂环类化合物作为β2-肾上腺素受体别构调节剂的应用
|